PURE Bioscience Announces Ten Year $144 Million Contract

PURE Bioscience PURE yesterday reported in its quarterly investor call that High Scope Trading LLC of Dubai has contractually committed to more than $144 million in orders over the next 10 years with an initial focus on sales of SDC-based IV-7 Water Treatment.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsContractsHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!